カテゴリー： QYResearch, 世界

女性用性機能障害治療の世界市場：規模・現状・予測

◆英語タイトル：Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18465
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：95
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、女性用性機能障害治療の世界市場について調査・分析し、女性用性機能障害治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非ホルモン療法、ホルモン療法）、用途別（性的欲求障害、性的興奮障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能障害、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の女性用性機能障害治療市場動向
・主要企業別マーケットシェア
・女性用性機能障害治療の種類別市場規模2014-2019
（非ホルモン療法、ホルモン療法）
・女性用性機能障害治療の用途別市場規模2014-2019
（性的欲求障害、性的興奮障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能障害、その他）
・女性用性機能障害治療の北米市場：主要企業・種類別/用途別市場規模
・女性用性機能障害治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・女性用性機能障害治療の中国市場：主要企業・種類別/用途別市場規模
・女性用性機能障害治療の日本国内市場：主要企業・種類別/用途別市場規模
・女性用性機能障害治療の東南アジア市場：主要企業・種類別/用途別市場規模
・女性用性機能障害治療のインド市場：主要企業・種類別/用途別市場規模
・女性用性機能障害治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（AMAG Pharmaceuticals Inc.、Duchesnay Inc.、Emotional Brain BV、Novo Nordisk AS、Sprout Pharmaceuticals Inc.）
・女性用性機能障害治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market during the forecast period. Women suffering from chronic health conditions such as diabetes may also be diagnosed with sexual dysfunction. Clinical indications, including hypertension, obesity, metabolic syndrome, and atherogenic dyslipidemia, of chronic conditions such as diabetes, are the risk factors for sexual dysfunctions in women. The rising prevalence of chronic health conditions in women will increase the incidence of female sexual dysfunctions. This will provide considerable growth opportunities to market participants.

Mental health conditions such as depression are being recognized as critical health issues mostly among women. As a result, many pharmaceutical companies are releasing drugs and therapies to treat these conditions leading to an increase in the consumption of antidepressants, antipsychotics, and antiepileptics. Moreover, there is also an increase in the consumption of contraceptives. These drugs cause sexual dysfunctions in women.
In 2018, the global Female Sexual Dysfunction Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Female Sexual Dysfunction Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Female Sexual Dysfunction Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
AMAG Pharmaceuticals Inc.
Duchesnay Inc.
Emotional Brain BV
Novo Nordisk AS
Sprout Pharmaceuticals Inc.
…

Market segment by Type, the product can be split into
Non-hormonal Therapy
Hormonal Therapy

Market segment by Application, split into
Sexual Desire Disorders
Sexual Arousal Disorders
Orgasm Disorders
Sexual Pain Disorders
Post-orgasmic Diseases
Pelvic Floor Dysfunction
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Female Sexual Dysfunction Treatment status, future forecast, growth opportunity, key market and key players.
To present the Female Sexual Dysfunction Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Female Sexual Dysfunction Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-hormonal Therapy
1.4.3 Hormonal Therapy
1.5 Market by Application
1.5.1 Global Female Sexual Dysfunction Treatment Market Share by Application (2019-2025)
1.5.2 Sexual Desire Disorders
1.5.3 Sexual Arousal Disorders
1.5.4 Orgasm Disorders
1.5.5 Sexual Pain Disorders
1.5.6 Post-orgasmic Diseases
1.5.7 Pelvic Floor Dysfunction
1.5.8 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Female Sexual Dysfunction Treatment Market Size
2.2 Female Sexual Dysfunction Treatment Growth Trends by Regions
2.2.1 Female Sexual Dysfunction Treatment Market Size by Regions (2019-2025)
2.2.2 Female Sexual Dysfunction Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Female Sexual Dysfunction Treatment Market Size by by Players
3.1.1 Global Female Sexual Dysfunction Treatment Revenue by by Players (2014-2019)
3.1.2 Global Female Sexual Dysfunction Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Female Sexual Dysfunction Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Female Sexual Dysfunction Treatment Key Players Head office and Area Served
3.3 Key Players Female Sexual Dysfunction Treatment Product/Solution/Service
3.4 Date of Enter into Female Sexual Dysfunction Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Female Sexual Dysfunction Treatment Market Size by Type (2014-2019)
4.2 Global Female Sexual Dysfunction Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Female Sexual Dysfunction Treatment Market Size (2014-2019)
5.2 Female Sexual Dysfunction Treatment Key Players in North America
5.3 North America Female Sexual Dysfunction Treatment Market Size by Type
5.4 North America Female Sexual Dysfunction Treatment Market Size by Application

6 Europe
6.1 Europe Female Sexual Dysfunction Treatment Market Size (2014-2019)
6.2 Female Sexual Dysfunction Treatment Key Players in Europe
6.3 Europe Female Sexual Dysfunction Treatment Market Size by Type
6.4 Europe Female Sexual Dysfunction Treatment Market Size by Application

7 China
7.1 China Female Sexual Dysfunction Treatment Market Size (2014-2019)
7.2 Female Sexual Dysfunction Treatment Key Players in China
7.3 China Female Sexual Dysfunction Treatment Market Size by Type
7.4 China Female Sexual Dysfunction Treatment Market Size by Application

8 Japan
8.1 Japan Female Sexual Dysfunction Treatment Market Size (2014-2019)
8.2 Female Sexual Dysfunction Treatment Key Players in Japan
8.3 Japan Female Sexual Dysfunction Treatment Market Size by Type
8.4 Japan Female Sexual Dysfunction Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Female Sexual Dysfunction Treatment Market Size (2014-2019)
9.2 Female Sexual Dysfunction Treatment Key Players in Southeast Asia
9.3 Southeast Asia Female Sexual Dysfunction Treatment Market Size by Type
9.4 Southeast Asia Female Sexual Dysfunction Treatment Market Size by Application

10 India
10.1 India Female Sexual Dysfunction Treatment Market Size (2014-2019)
10.2 Female Sexual Dysfunction Treatment Key Players in India
10.3 India Female Sexual Dysfunction Treatment Market Size by Type
10.4 India Female Sexual Dysfunction Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Female Sexual Dysfunction Treatment Market Size (2014-2019)
11.2 Female Sexual Dysfunction Treatment Key Players in Central & South America
11.3 Central & South America Female Sexual Dysfunction Treatment Market Size by Type
11.4 Central & South America Female Sexual Dysfunction Treatment Market Size by Application

12 International Players Profiles
12.1 AMAG Pharmaceuticals Inc.
12.1.1 AMAG Pharmaceuticals Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Female Sexual Dysfunction Treatment Introduction
12.1.4 AMAG Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2014-2019))
12.1.5 AMAG Pharmaceuticals Inc. Recent Development
12.2 Duchesnay Inc.
12.2.1 Duchesnay Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Female Sexual Dysfunction Treatment Introduction
12.2.4 Duchesnay Inc. Revenue in Female Sexual Dysfunction Treatment Business (2014-2019)
12.2.5 Duchesnay Inc. Recent Development
12.3 Emotional Brain BV
12.3.1 Emotional Brain BV Company Details
12.3.2 Company Description and Business Overview
12.3.3 Female Sexual Dysfunction Treatment Introduction
12.3.4 Emotional Brain BV Revenue in Female Sexual Dysfunction Treatment Business (2014-2019)
12.3.5 Emotional Brain BV Recent Development
12.4 Novo Nordisk AS
12.4.1 Novo Nordisk AS Company Details
12.4.2 Company Description and Business Overview
12.4.3 Female Sexual Dysfunction Treatment Introduction
12.4.4 Novo Nordisk AS Revenue in Female Sexual Dysfunction Treatment Business (2014-2019)
12.4.5 Novo Nordisk AS Recent Development
12.5 Sprout Pharmaceuticals Inc.
12.5.1 Sprout Pharmaceuticals Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Female Sexual Dysfunction Treatment Introduction
12.5.4 Sprout Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2014-2019)
12.5.5 Sprout Pharmaceuticals Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Female Sexual Dysfunction Treatment Key Market Segments
Table Key Players Female Sexual Dysfunction Treatment Covered
Table Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Non-hormonal Therapy Figures
Table Key Players of Non-hormonal Therapy
Figuer Hormonal Therapy Figures
Table Key Players of Hormonal Therapy
Table Global Female Sexual Dysfunction Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Female Sexual Dysfunction Treatment Market Share by Application in 2018 & 2025
Figure Sexual Desire Disorders Case Studies
Figure Sexual Arousal Disorders Case Studies
Figure Orgasm Disorders Case Studies
Figure Sexual Pain Disorders Case Studies
Figure Post-orgasmic Diseases Case Studies
Figure Pelvic Floor Dysfunction Case Studies
Figure Other Case Studies
Figure Female Sexual Dysfunction Treatment Report Years Considered
Figure Global Female Sexual Dysfunction Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Female Sexual Dysfunction Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Female Sexual Dysfunction Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Female Sexual Dysfunction Treatment Market Share by Regions 2014-2019
Figure Global Female Sexual Dysfunction Treatment Market Share by Regions 2014-2019
Figure Global Female Sexual Dysfunction Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Female Sexual Dysfunction Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Female Sexual Dysfunction Treatment Market Share by by Players (2014-2019)
Figure Global Female Sexual Dysfunction Treatment Market Share by by Players in 2018
Table Global Female Sexual Dysfunction Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Female Sexual Dysfunction Treatment Product/Solution/Service
Table Date of Enter into Female Sexual Dysfunction Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Female Sexual Dysfunction Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Female Sexual Dysfunction Treatment Market Size Share by Type (2014-2019)
Figure Global Female Sexual Dysfunction Treatment Market Size Market Share by Type (2014-2019)
Table Global Female Sexual Dysfunction Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Female Sexual Dysfunction Treatment Market Size Share by Application (2014-2019)
Figure Global Female Sexual Dysfunction Treatment Market Size Market Share by Application (2014-2019)
Figure Global Female Sexual Dysfunction Treatment Revenue Market Share by Application in 2018
Figure North America Female Sexual Dysfunction Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Female Sexual Dysfunction Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Female Sexual Dysfunction Treatment Market Share (2018-2019)
Table North America Female Sexual Dysfunction Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Female Sexual Dysfunction Treatment Market Share by Type 2014-2019
Table North America Female Sexual Dysfunction Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Female Sexual Dysfunction Treatment Market Share by Application 2014-2019
Figure Europe Female Sexual Dysfunction Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Female Sexual Dysfunction Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Female Sexual Dysfunction Treatment Market Share (2018-2019)
Table Europe Female Sexual Dysfunction Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Female Sexual Dysfunction Treatment Market Share by Type 2014-2019
Table Europe Female Sexual Dysfunction Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Female Sexual Dysfunction Treatment Market Share by Application 2014-2019
Figure China Female Sexual Dysfunction Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Female Sexual Dysfunction Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Female Sexual Dysfunction Treatment Market Share (2018-2019)
Table China Female Sexual Dysfunction Treatment Market Size by Type 2014-2019 (Million US$)
Table China Female Sexual Dysfunction Treatment Market Share by Type 2014-2019
Table China Female Sexual Dysfunction Treatment Market Size by Application 2014-2019 (Million US$)
Table China Female Sexual Dysfunction Treatment Market Share by Application 2014-2019
Figure Japan Female Sexual Dysfunction Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Female Sexual Dysfunction Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Female Sexual Dysfunction Treatment Market Share (2018-2019)
Table Japan Female Sexual Dysfunction Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Female Sexual Dysfunction Treatment Market Share by Type 2014-2019
Table Japan Female Sexual Dysfunction Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Female Sexual Dysfunction Treatment Market Share by Application 2014-2019
Figure Southeast Asia Female Sexual Dysfunction Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Female Sexual Dysfunction Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Female Sexual Dysfunction Treatment Market Share (2018-2019)
Table Southeast Asia Female Sexual Dysfunction Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Female Sexual Dysfunction Treatment Market Share by Type 2014-2019
Table Southeast Asia Female Sexual Dysfunction Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Female Sexual Dysfunction Treatment Market Share by Application 2014-2019
Figure India Female Sexual Dysfunction Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Female Sexual Dysfunction Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Female Sexual Dysfunction Treatment Market Share (2018-2019)
Table India Female Sexual Dysfunction Treatment Market Size by Type 2014-2019 (Million US$)
Table India Female Sexual Dysfunction Treatment Market Share by Type 2014-2019
Table India Female Sexual Dysfunction Treatment Market Size by Application 2014-2019 (Million US$)
Table India Female Sexual Dysfunction Treatment Market Share by Application 2014-2019
Figure Central & South America Female Sexual Dysfunction Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Female Sexual Dysfunction Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Female Sexual Dysfunction Treatment Market Share (2018-2019)
Table Central & South America Female Sexual Dysfunction Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Female Sexual Dysfunction Treatment Market Share by Type 2014-2019
Table Central & South America Female Sexual Dysfunction Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Female Sexual Dysfunction Treatment Market Share by Application 2014-2019
Table AMAG Pharmaceuticals Inc. Company Details
Table AMAG Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business 2014-2019 (Million US$)
Figure AMAG Pharmaceuticals Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2014-2019)
Table AMAG Pharmaceuticals Inc. Recent Development
Table Duchesnay Inc. Company Details
Table Duchesnay Inc. Revenue in Female Sexual Dysfunction Treatment Business 2014-2019 (Million US$)
Figure Duchesnay Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2014-2019)
Table Duchesnay Inc. Recent Development
Table Emotional Brain BV Company Details
Table Emotional Brain BV Revenue in Female Sexual Dysfunction Treatment Business 2014-2019 (Million US$)
Figure Emotional Brain BV Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2014-2019)
Table Emotional Brain BV Recent Development
Table Novo Nordisk AS Company Details
Table Novo Nordisk AS Revenue in Female Sexual Dysfunction Treatment Business 2014-2019 (Million US$)
Figure Novo Nordisk AS Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2014-2019)
Table Novo Nordisk AS Recent Development
Table Sprout Pharmaceuticals Inc. Company Details
Table Sprout Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business 2014-2019 (Million US$)
Figure Sprout Pharmaceuticals Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2014-2019)
Table Sprout Pharmaceuticals Inc. Recent Development
Table Global Female Sexual Dysfunction Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Female Sexual Dysfunction Treatment Market Size Share by Regions (2019-2025)
Figure Global Female Sexual Dysfunction Treatment Market Size Share by Regions in 2025
Figure North America Female Sexual Dysfunction Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Female Sexual Dysfunction Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Female Sexual Dysfunction Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Female Sexual Dysfunction Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Female Sexual Dysfunction Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Female Sexual Dysfunction Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Female Sexual Dysfunction Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Female Sexual Dysfunction Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Female Sexual Dysfunction Treatment Market Size by Product (2019-2025)
Figure Global Female Sexual Dysfunction Treatment Market Size by Product in 2025
Table Global Female Sexual Dysfunction Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Female Sexual Dysfunction Treatment Market Size by Application (2019-2025)
Figure Global Female Sexual Dysfunction Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

AMAG Pharmaceuticals Inc.、Duchesnay Inc.、Emotional Brain BV、Novo Nordisk AS、Sprout Pharmaceuticals Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 女性用性機能障害治療の世界市場：規模・現状・予測(Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp